Cargando…

2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin

BACKGROUND: Studies using molecular testing methods have found monomicrobial infection with a virus as the etiology of CAP in adult patients admitted to the hospital in 6–30% of cases. The use of antibacterial agents in such patients is unnecessary, and can lead to untoward consequences. A test conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Politis, Paula Ann, Kallstrom, George, Tan, Michael, File, Thomas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810142/
http://dx.doi.org/10.1093/ofid/ofz360.1915
_version_ 1783462175920095232
author Politis, Paula Ann
Kallstrom, George
Tan, Michael
File, Thomas M
author_facet Politis, Paula Ann
Kallstrom, George
Tan, Michael
File, Thomas M
author_sort Politis, Paula Ann
collection PubMed
description BACKGROUND: Studies using molecular testing methods have found monomicrobial infection with a virus as the etiology of CAP in adult patients admitted to the hospital in 6–30% of cases. The use of antibacterial agents in such patients is unnecessary, and can lead to untoward consequences. A test confirming a viral etiology may reduce the needless use of antibiotics, especially if the procalcitonin (PCT) level is low, suggesting that bacterial co-infection is unlikely. Our Antimicrobial Stewardship Program (ASP) routinely follows patients admitted with respiratory tract infections, and provides recommendations for appropriate therapy based on diagnostic test results as well as PCT levels. We present a retrospective evaluation of our experience. METHODS: A retrospective review of ASP interventions on patients admitted to Summa Health System—Akron Campus was performed for the time frame of January 2018–March 2019. Patients were included if they had a positive viral PCR result (VERIGENE™, BioFire™), a PCT level <0.25 ng/mL (BioMérieux™, Abbott™), negative bacterial studies, and an accepted intervention to discontinue antimicrobial therapy made by the ASP. RESULTS: The ASP assessed 131 patients with positive viral PCR studies and low PCT levels who had antimicrobials discontinued based on ASP recommendations; 68 with CAP and 63 without pneumonia (WPNA) as demonstrated on imaging. Most patients in the WPNA category had acute exacerbation of COPD. Common viruses identified were Influenza A or B, Rhinovirus and RSV. Mean duration of antibiotics was 2.6 days for CAP and 2.4 days for WPNA (Table 1). The 30-day readmission rate was similar for each group, and for CAP patients was similar for all-cause pneumonia patients at our institution (14% during similar time period). 30-day Mortality of CAP patients was low. CONCLUSION: While national guidelines recommend a minimum of 5 days of antimicrobial therapy for CAP patients, we have observed that discontinuing antibiotics well before that is safe if a viral etiology is identified without evidence of bacterial co-infection (including low PCT) and results in less antibiotic usage. Reduction in unnecessary antibiotic use has the potential to improve the quality of care for adults with CAP. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810142
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68101422019-10-28 2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin Politis, Paula Ann Kallstrom, George Tan, Michael File, Thomas M Open Forum Infect Dis Abstracts BACKGROUND: Studies using molecular testing methods have found monomicrobial infection with a virus as the etiology of CAP in adult patients admitted to the hospital in 6–30% of cases. The use of antibacterial agents in such patients is unnecessary, and can lead to untoward consequences. A test confirming a viral etiology may reduce the needless use of antibiotics, especially if the procalcitonin (PCT) level is low, suggesting that bacterial co-infection is unlikely. Our Antimicrobial Stewardship Program (ASP) routinely follows patients admitted with respiratory tract infections, and provides recommendations for appropriate therapy based on diagnostic test results as well as PCT levels. We present a retrospective evaluation of our experience. METHODS: A retrospective review of ASP interventions on patients admitted to Summa Health System—Akron Campus was performed for the time frame of January 2018–March 2019. Patients were included if they had a positive viral PCR result (VERIGENE™, BioFire™), a PCT level <0.25 ng/mL (BioMérieux™, Abbott™), negative bacterial studies, and an accepted intervention to discontinue antimicrobial therapy made by the ASP. RESULTS: The ASP assessed 131 patients with positive viral PCR studies and low PCT levels who had antimicrobials discontinued based on ASP recommendations; 68 with CAP and 63 without pneumonia (WPNA) as demonstrated on imaging. Most patients in the WPNA category had acute exacerbation of COPD. Common viruses identified were Influenza A or B, Rhinovirus and RSV. Mean duration of antibiotics was 2.6 days for CAP and 2.4 days for WPNA (Table 1). The 30-day readmission rate was similar for each group, and for CAP patients was similar for all-cause pneumonia patients at our institution (14% during similar time period). 30-day Mortality of CAP patients was low. CONCLUSION: While national guidelines recommend a minimum of 5 days of antimicrobial therapy for CAP patients, we have observed that discontinuing antibiotics well before that is safe if a viral etiology is identified without evidence of bacterial co-infection (including low PCT) and results in less antibiotic usage. Reduction in unnecessary antibiotic use has the potential to improve the quality of care for adults with CAP. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810142/ http://dx.doi.org/10.1093/ofid/ofz360.1915 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Politis, Paula Ann
Kallstrom, George
Tan, Michael
File, Thomas M
2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin
title 2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin
title_full 2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin
title_fullStr 2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin
title_full_unstemmed 2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin
title_short 2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin
title_sort 2237. early discontinuation of antibacterials is safe for patients with community-acquired pneumonia (cap) who have a positive viral test, negative tests for bacteria, and low procalcitonin
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810142/
http://dx.doi.org/10.1093/ofid/ofz360.1915
work_keys_str_mv AT politispaulaann 2237earlydiscontinuationofantibacterialsissafeforpatientswithcommunityacquiredpneumoniacapwhohaveapositiveviraltestnegativetestsforbacteriaandlowprocalcitonin
AT kallstromgeorge 2237earlydiscontinuationofantibacterialsissafeforpatientswithcommunityacquiredpneumoniacapwhohaveapositiveviraltestnegativetestsforbacteriaandlowprocalcitonin
AT tanmichael 2237earlydiscontinuationofantibacterialsissafeforpatientswithcommunityacquiredpneumoniacapwhohaveapositiveviraltestnegativetestsforbacteriaandlowprocalcitonin
AT filethomasm 2237earlydiscontinuationofantibacterialsissafeforpatientswithcommunityacquiredpneumoniacapwhohaveapositiveviraltestnegativetestsforbacteriaandlowprocalcitonin